Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

ExLabs partners with Japan’s Chiba Institute of Technology (ChibaTech) and its Planetary Exploration Research Center (PERC) ...

This week marks the 20th anniversary of the original MacBook Pro. In the spirit of this article, I’m going to review it as if ...

Former MEP Cyrus Engerer has called for the creation of a European Defence Union, warning that Europe is entering its most ...

The controversy surrounding Fort Tigné has been framed as a clash between development and heritage. In reality, it says far ...

New York, New York - January 06, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has announced continued development and ...

European officials and tech campaigners on Friday slammed Elon Musk's AI chatbot Grok after its controversial image creation ...

The town of Marana, Arizona, has approved rezoning for a new data center, putting it in direct competition with Project Blue ...

The Ebook delves into key radio frequency (RF) design topics ranging from signal chain fundamentals and antenna selection to ...

Daviess County Judge-Executive Charlie Castlen delivered his “State of the County” address Thursday during the Greater ...

The Bulls N’ Bears ASX Runner of the Week is… Hydrix Ltd, which locked in a $2.5 million deal to develop SynCardia’s next-gen ...

For over 60 years, the search for an effective pharmacologic treatment for refractory or unexplained chronic cough has been ...